An Integrated Workflow for Peptide Mapping of Monoclonal Antibodies
Applications | 2017 | Agilent TechnologiesInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma, Proteomics
ManufacturerAgilent Technologies
Key wordspeptide, mab, mapping, counts, assaymap, sgtasvvcllnnfypr, acquisition, workflow, charge, sequence, were, digestion, nist, diqmtqspstlsasvgdrvtitcsassr, mtqspstlsasvgdrvtitcsassr, digested, diq, lliydtsk, deamidation, coverage, data, agilent, vyacevthqglsspvtk, mass, peptides, sample, solution, native, met, monoclonal, min, modifications, protein, predominant, time, system, from, highly, automated, form, asparagine, advancebio, enzymatic, preparation, alewladiw, lidded, precursors, reproducibility, spectra, oxidation
Similar PDF
In-depth Peptide Mapping with Iterative MS/MS Acquisition on the Agilent 6545XT AdvanceBio LC/Q‑TOF
2020|Agilent Technologies|Applications
Application Note Biotherapeutics and Biosimilars In-depth Peptide Mapping with Iterative MS/MS Acquisition on the Agilent 6545XT AdvanceBio LC/Q‑TOF Authors Introduction Linfeng Wu and David L. Wong Agilent Technologies, Inc. Santa Clara, CA, USA Therapeutic monoclonal antibodies (mAbs) represent one of…
Key words
ntaylqmnslr, ntaylqmnslriterative, iterativepeptide, peptidemapping, mappingcounts, countsauto, autoacquisition, acquisitionassaymap, assaymapcharge, chargeprecursors, precursorseccs, eccsbravo, bravomass, massisoasp, isoaspagilent
Making Peptide Mapping Routine with the Agilent 6545XT AdvanceBio LC/Q-TOF
2017|Agilent Technologies|Applications
Making Peptide Mapping Routine with the Agilent 6545XT AdvanceBio LC/Q-TOF Application Note Authors Introduction David L. Wong Monoclonal antibodies (mAbs) comprise a rapidly growing group of protein-based biomolecules being researched. Due to the heterogeneous nature of protein drugs, extensive analytical…
Key words
peptide, peptidemapping, mappingpeptides, peptidesadvancebio, advancebioassaymap, assaymapagilent, agilentbravo, bravonqvsltclvk, nqvsltclvkcharge, chargecounts, countsnative, nativemonoclonal, monoclonalantibody, antibodymass, massbioconfirm
LC/MS/MS Peptide Mapping Comparison of Innovator and Biosimilars of Rituximab
2019|Agilent Technologies|Applications
Application Note Biotherapeutics and Biosimilars LC/MS/MS Peptide Mapping Comparison of Innovator and Biosimilars of Rituximab Author Suresh Babu C.V. Agilent Technologies, Inc. Abstract The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products. This Application Note presents…
Key words
innovator, innovatorpeptide, peptidecounts, countschain, chainmapping, mappingbiosimilar, biosimilarcharge, chargeunmodified, unmodifiedptms, ptmsheavy, heavyassaymap, assaymapbravo, bravomabs, mabsbiosimilars, biosimilarsttppvldsdgsfflyskl
Enhancing The Quality Of Peptide Mapping Separation For The Analysis Of PTM
2017|Agilent Technologies|Applications
Enhancing The Quality Of Peptide Mapping Separation For The Analysis Of PTM Application Note Biotherapeutics and Biosimilars Author Introduction Suresh Babu C.V. Post-translational modifications (PTMs) on proteins such as monoclonal antibodies (mAbs) are critical quality attributes (CQAs) that define the…
Key words
peptide, peptidecounts, countsntaylqmnslr, ntaylqmnslradvancebio, advancebiodltmisr, dltmisrmab, mabeeeqynstr, eeeqynstrptms, ptmsdeamidated, deamidatedplus, plusdigest, digestmapping, mappingseparation, separationtryptic, trypticnonoxidized